Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
COMPLETED
NCT02719496
PHASE2
Prove of Concept Study, to Evaluate the Efficacy, Safety, and Tolerability of IBEROGAST in the Treatment of Bowel Troubles in Patients With Parkinson's Disease
Sponsor: Nantes University Hospital
View on ClinicalTrials.gov
Summary
The main objective of this study is to evaluate the efficacy of STW5 Iberogast, over a 28-day period, for the treatment of constipation in parkinsonian patients suffering from gastrointestinal disorders.
Key Details
Gender
All
Age Range
30 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
45
Start Date
2016-04
Completion Date
2018-04
Last Updated
2026-09-14
Healthy Volunteers
No
Interventions
DRUG
IBEROGAST
Locations (1)
Tiphaine Rouaud
Nantes, France